Literature DB >> 11757957

Chronic bilateral pallidal stimulation and levodopa do not improve gait in the same way in Parkinson's disease: a study using a video motion analysis system.

P Krystkowiak1, J L Blatt, J L Bourriez, A Duhamel, M Perina, G Kemoun, S Blond, J D Guieu, A Destée, L Defebvre.   

Abstract

Chronic bilateral internal globus pallidus (GPi) stimulation allows control of levodopa induced dyskinesias (LID) and motor symptoms in severe Parkinson's disease (PD). The effect on gait has not been clearly established. Different results have been reported, mostly consisting of clinical data. The aim of this study was to evaluate, by means of a video motion analysis system (optoelectronic VICON system), the influence of bilateral GPi stimulation on gait in PD. Five patients underwent bilateral GPi stimulation. The preoperative and postoperative (3 months after surgery) clinical gait disturbances (items 29 and 30 of the motor UPDRS), as well as spatial and temporal gait measurements (namely cadence, velocity, stride and step times, single and double limb support times, stride and step lengths) were analysed in off condition (the patient had received no treatment for 12 hours or merely the lowest dose of levodopa allowing him to walk for the gait analysis) and in the on drug condition (after administration of 200 mg of levodopa). The gait analysis was performed with the VICON system. In off condition, there was a statistically significant improvement after surgery for UPDRS III and gait (clinically assessed). In on drug condition, there was a significant improvement for LID whereas UPDRS III and clinical assessment of gait were unchanged. The VICON system also showed that surgery improved gait especially in off condition, but also in on drug condition. Our method allowed exact quantification of the influence of surgery on gait characteristics. As compared with levodopa treatment, the effect of stimulation seems to be different. Indeed, the results suggest only limited effects of pallidal stimulation on the control of stride length and rather point to compensatory additional mechanisms.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11757957     DOI: 10.1007/s004150170046

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  4 in total

1.  Evolution of postural stability after subthalamic nucleus stimulation in Parkinson's disease: a combined clinical and posturometric study.

Authors:  D Guehl; P Dehail; M P de Sèze; E Cuny; P Faux; F Tison; M Barat; B Bioulac; P Burbaud
Journal:  Exp Brain Res       Date:  2005-11-19       Impact factor: 1.972

2.  Role of hypokinesia and bradykinesia in gait disturbances in Huntington's disease: a biomechanical study.

Authors:  Arnaud Delval; Pierre Krystkowiak; Jean-Louis Blatt; Etienne Labyt; Kathy Dujardin; Alain Destée; Philippe Derambure; Luc Defebvre
Journal:  J Neurol       Date:  2005-08-17       Impact factor: 4.849

3.  Surgical management of Parkinson's disease: update and review.

Authors:  Y Chao; L Gang; Z L Na; W Y Ming; W S Zhong; W S Mian
Journal:  Interv Neuroradiol       Date:  2008-02-01       Impact factor: 1.610

4.  Gait abnormalities induced by acquired bilateral pallidal lesions: a motion analysis study.

Authors:  P Krystkowiak; A Delval; K Dujardin; S Bleuse; J L Blatt; J L Bourriez; P Derambure; A Destée; L Defebvre
Journal:  J Neurol       Date:  2006-03-13       Impact factor: 4.849

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.